Prophylactic antibiotics in oral, pharyngeal and laryngeal surgery for cancer: (a double-blind study).
D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000302:isolation & purification; D002986:Clinical Trials as Topic; D003023:Cloxacillin / Q000008:administration & dosage / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D007822:Laryngeal Neoplasms / Q000601:surgery*; D009062:Mouth Neoplasms / Q000601:surgery*; D010403:Penicillin Resistance; D010610:Pharyngeal Neoplasms / Q000601:surgery*; D010919:Placebos; D011183:Postoperative Complications / Q000517:prevention & control*; D012141:Respiratory Tract Infections / Q000382:microbiology / Q000517:prevention & control*; D013530:Surgical Wound Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D010919:Placebos; D000667:Ampicillin; D003023:Cloxacillin